Putnam develop an early oncology portfolio execution roadmap
Putnam, an Inizio Advisory company, developed a forward-looking early development program evaluation tool that identifies key inflection points, value drivers and risks for their client’s early oncology portfolio.
Read more about the client’s challenge, Putnam’s solution and the results.
Discover more about how we help to shape the future of oncology treatments here.
Jump to a slide with the slide dots.
How can AI-augmented analysis accelerate Scientific Communications Platforms (SCPs)?
To power faster, insight-rich scientific content, Inizio Medical helped a global pharmaceutical company transform their...
Read moreHow can biopharma companies accelerate indication strategy in rare endocrine disorders?
To shape a growth franchise in rare endocrine disorders, our experts enabled faster, data-driven indication decisions using AssetNav.
Read moreHow does ClarityNav turn medical insights into strategic action for product launch success?
By integrating multimodal medical insight data sources, we developed a framework that transforms complex datasets into actionable recommendations.
Read more